Orthopedic Regenerative Surgical Products Market Size Is Expected To Reach USD 5.2 Billion By 2028
San Francisco, 20 Sep 2021: The Report Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report By Product (Allograft, Synthetic, Cell-based, Viscosupplements), By Application, By End User (Hospitals, Ambulatory Surgical Centers), And Segment Forecasts, 2021 - 2028 The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.2 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 3.6% from 2021 to 2028. The key factors driving the market growth include the rising geriatric population, orthopedic procedures, research activities, and technological advancements. Osteoarthritis, for instance, has been identified as the leading cause of chronic disability in the geriatric population over the age of 70. The World Health Organization (WHO) has also designated osteoarthritis as a ‘priority disease’ promoting R&D for therapies to treat osteoarthrit